Journals - All Articles

Medicines are being developed for diseases that were previously untreatable, and new technologies such as cell and gene therapies, gene editing (ATMPs), Antibody Drug Conjugates (ADCs), and Lipid Nano Particles (LNPs) are providing new ways to target these diseases.

Review of Developments in GMP and the Regulation of Medicines December 2025  EJPPS Volume 30.4C INTRODUCTION During the last 4 weeks there have been a number of developments in the regulation of the pharmaceutical industry. This month reported issues have come from the UK, EU, USA and Swiss regulatory authorities. The topics covered in this edition of the “Update” include: UK Medicines and Healthcare products Regulatory Agency (MHRA) ·       Three convicted in major MHRA inve

Review of Developments in GMP and the Regulation of Medicines November 2025  EJPPS Volume 30.4B  INTRODUCTION During the last 4 weeks there have been a number of developments in the regulation of the pharmaceutical industry. This month reported issues have come from the UK, EU, Australia and PIC/S regulatory authorities. The topics covered in this edition of the “Update” include: UK Medicines and Healthcare products Regulatory Agency (MHRA) ·       Regulation in an age of per